InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Starr Christopher M, 董事. Officer active across 1 company, notably Monopar Therapeutics. In total, 12 filings have been published. History available since 14 July 2025. The latest transaction was filed on 14 July 2025 (X). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Starr Christopher M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
16,800 股@ US$0.005100.0% 占其流量Common StockSEC:0001437749-25-022862:0
2,533 股Common StockSEC:0001437749-24-000483:0
2,533 股Common StockSEC:0001437749-23-027586:0
2,534 股Common StockSEC:0001437749-23-019259:0
2,533 股Common StockSEC:0001437749-23-009337:0
2,859 股Common StockSEC:0001437749-23-000170:0
2,859 股Common StockSEC:0001654954-22-013281:0
2,859 股Common StockSEC:0001654954-22-009137:0
2,859 股Common StockSEC:0001654954-22-004480:0
751 股Common StockSEC:0001654954-22-000118:0
751 股Common StockSEC:0001654954-21-010718:0
752 股Common StockSEC:0001654954-21-007605:0
12 条申报中的 12 条
About Starr Christopher M
STARR CHRISTOPHER M is Administrateur at Monopar Therapeutics (XNAS). He has 12 filings in total, and the sampled recent filings cover the period from 2021-07-02 to 2025-07-16. The most common transaction nature is Levée d'options, and the buy and sell volumes shown for this recent sample are EUR 0 and EUR 0.
